Spots Global Cancer Trial Database for ganglioneuroblastoma
Every month we try and update this database with for ganglioneuroblastoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| SIOPEN BIOPORTAL, An International Registry Linked to a Virtual Biobank for Patients With Peripheral Neuroblastic Tumours | NCT05192980 | Neuroblastoma Ganglioneurobla... Ganglioneuroma | No Intervention... | - | Institut Curie | |
| Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma | NCT03786783 | Ganglioneurobla... High Risk Neuro... | Autologous Hema... Carboplatin Cisplatin Cyclophosphamid... Dexrazoxane Dinutuximab Doxorubicin Etoposide External Beam R... Isotretinoin Melphalan Sargramostim Thiotepa Topotecan Vincristine | - 30 Years | National Cancer Institute (NCI) | |
| Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma | NCT01798004 | Ganglioneurobla... Stage 1 Neurobl... Stage 2 Neurobl... Stage 2A Neurob... Stage 2B Neurob... Stage 3 Neurobl... Stage 4 Neurobl... Stage 4S Neurob... | Autologous Hema... Busulfan Cisplatin Cyclophosphamid... Doxorubicin Hyd... Etoposide External Beam R... Filgrastim Laboratory Biom... Melphalan Mesna Peripheral Bloo... Pharmacological... Topotecan Hydro... Vincristine Sul... | - 30 Years | Children's Oncology Group | |
| SIOPEN BIOPORTAL, An International Registry Linked to a Virtual Biobank for Patients With Peripheral Neuroblastic Tumours | NCT05192980 | Neuroblastoma Ganglioneurobla... Ganglioneuroma | No Intervention... | - | Institut Curie | |
| An Investigational Scan (68Ga-DOTATATE PET/CT) in Diagnosing Pediatric Metastatic Neuroendocrine Tumors | NCT04040088 | Ganglioneurobla... Ganglioneuroma Neuroblastoma | Computed Tomogr... Gallium Ga 68-D... Positron Emissi... | - 30 Years | Mayo Clinic | |
| Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in Treating Younger Patients With Refractory or Relapsed Neuroblastoma | NCT01767194 | Ganglioneurobla... Recurrent Neuro... | Dinutuximab Irinotecan Hydr... Laboratory Biom... Sargramostim Temozolomide Temsirolimus | - | National Cancer Institute (NCI) | |
| Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma | NCT01798004 | Ganglioneurobla... Stage 1 Neurobl... Stage 2 Neurobl... Stage 2A Neurob... Stage 2B Neurob... Stage 3 Neurobl... Stage 4 Neurobl... Stage 4S Neurob... | Autologous Hema... Busulfan Cisplatin Cyclophosphamid... Doxorubicin Hyd... Etoposide External Beam R... Filgrastim Laboratory Biom... Melphalan Mesna Peripheral Bloo... Pharmacological... Topotecan Hydro... Vincristine Sul... | - 30 Years | Children's Oncology Group | |
| Abdominal Neuroblastoma Laparoscopic Surgery Risk Factors Stratification | NCT06296732 | Neuroblastoma Ganglioneuroma Ganglioneurobla... | Duration of sur... | 1 Day - 18 Years | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | |
| Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma | NCT00904241 | Ganglioneurobla... Localized Resec... Localized Unres... Regional Neurob... Stage 4 Neurobl... Stage 4S Neurob... | Cytology Specim... Laboratory Biom... | - 30 Years | Children's Oncology Group | |
| Induction Chemoimmunotherapy for Patients With High-risk Neuroblastoma | NCT06071897 | Neuroblastoma Ganglioneurobla... | monoclonal anti... | 18 Months - 18 Years | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | |
| Engineered Neuroblastoma Cellular Immunotherapy (ENCIT)-01 | NCT02311621 | Neuroblastoma Ganglioneurobla... | Patient Derived... Patient Derived... Patient Derived... | 18 Months - 26 Years | Seattle Children's Hospital | |
| Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma | NCT02176967 | Ganglioneurobla... Localized Resec... Localized Unres... Neuroblastoma | Biopsy Bone Marrow Asp... Bone Marrow Bio... Carboplatin Clinical Observ... Computed Tomogr... Cyclophosphamid... Doxorubicin Hyd... Etoposide Magnetic Resona... Ultrasound | - 18 Months | Children's Oncology Group | |
| Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin | NCT01175356 | Ganglioneurobla... Localized Resec... Localized Unres... Regional Neurob... Stage 4 Neurobl... Stage 4S Neurob... | 3-Dimensional C... Autologous Hema... Busulfan Cisplatin Cyclophosphamid... Doxorubicin Hyd... Etoposide Phosp... External Beam R... In Vitro-Treate... Intensity-Modul... Iobenguane I-13... Isotretinoin Laboratory Biom... Melphalan Pharmacological... Questionnaire A... Therapeutic Con... Topotecan Hydro... Vincristine Sul... | 1 Year - 30 Years | Children's Oncology Group | |
| Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma | NCT02176967 | Ganglioneurobla... Localized Resec... Localized Unres... Neuroblastoma | Biopsy Bone Marrow Asp... Bone Marrow Bio... Carboplatin Clinical Observ... Computed Tomogr... Cyclophosphamid... Doxorubicin Hyd... Etoposide Magnetic Resona... Ultrasound | - 18 Months | Children's Oncology Group | |
| International Congenital Central Hypoventilation Syndrome (CCHS) Registry | NCT03088020 | Congenital Cent... | - | Ann & Robert H Lurie Children's Hospital of Chicago |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
